A boronate prochelator built on a triazole framework for peroxide-triggered tridentate metal binding.
Ontology highlight
ABSTRACT: Iron chelating agents have the potential to minimize damage associated with oxidative stress in a range of diseases; however, this potential is countered by risks of indiscriminant metal binding or iron depletion in conditions not associated with systemic iron overload. Deferasirox is a chelator used clinically for iron overload, but also is cytotoxic to cells in culture. In order to test whether a prodrug version of deferasirox could minimize its cytotoxicity but retain its protective properties against iron-induced oxidative damage, we synthesized a prochelator that contains a self-immolative boronic ester masking group that is removed upon exposure to hydrogen peroxide to release the bis-hydroxyphenyltriazole ligand deferasirox. We present here the synthesis and characterization of this
SUBMITTER: Kielar F
PROVIDER: S-EPMC3579658 | biostudies-literature | 2012 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA